Profarma Distribuidora de Produtos Farmacêuticos S.A. (BVMF:PFRM3)
Brazil · Delayed Price · Currency is BRL 6.91
-0.18 (-2.54%)
Aug 6, 2026, 4:44 PM GMT-3
BVMF:PFRM3 Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 12,489 | 11,451 | 10,154 | 8,662 | 7,816 | 6,413 | |
Revenue Growth | 13.20% | 12.77% | 17.22% | 10.82% | 21.88% | 17.00% |
Cost of Revenue | 10,599 | 9,700 | 8,631 | 7,370 | 6,671 | 5,506 |
Gross Profit | 1,890 | 1,750 | 1,523 | 1,292 | 1,146 | 907.57 |
Selling, General & Admin | 1,473 | 1,369 | 1,225 | 1,046 | 916.83 | 668.28 |
Other Operating Expenses | 50.57 | 31.49 | -1.79 | -15.5 | -14.27 | -9.64 |
Operating Expenses | 1,523 | 1,400 | 1,223 | 1,031 | 902.56 | 771.32 |
Operating Income | 366.92 | 350.13 | 299.65 | 261.12 | 242.95 | 136.25 |
Interest Expense | -264.35 | -201.17 | -149.39 | -161.9 | -149.2 | -76.16 |
Interest & Investment Income | 14.53 | 14.53 | 8.3 | 10.95 | 8.68 | 4.9 |
Earnings From Equity Investments | -0.07 | -0.18 | 0.04 | 0.01 | -0.01 | 5.98 |
Other Non Operating Income (Expenses) | -21.89 | -45.85 | -30.74 | -28.59 | -23.46 | -10.71 |
EBT Excluding Unusual Items | 95.15 | 117.46 | 127.86 | 81.59 | 78.97 | 60.26 |
Impairment of Goodwill | - | - | - | - | - | -11.52 |
Other Unusual Items | 91.13 | - | - | - | - | - |
Pretax Income | 186.28 | 117.46 | 127.86 | 81.59 | 78.97 | 48.75 |
Income Tax Expense | 25.1 | -8.55 | 5.05 | 3.74 | -6.07 | -30.37 |
Earnings From Continuing Operations | 161.18 | 126.01 | 122.81 | 77.86 | 85.04 | 79.11 |
Minority Interest in Earnings | -6.64 | -7.12 | -8.23 | -7.46 | -4.17 | -0.92 |
Net Income | 154.54 | 118.9 | 114.58 | 70.4 | 80.87 | 78.19 |
Net Income to Common | 154.54 | 118.9 | 114.58 | 70.4 | 80.87 | 78.19 |
Net Income Growth | 30.95% | 3.77% | 62.76% | -12.96% | 3.43% | 49.41% |
Shares Outstanding (Basic) | - | 123 | 123 | 123 | 123 | 123 |
Shares Outstanding (Diluted) | - | 123 | 123 | 123 | 123 | 123 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | - | 0.97 | 0.93 | 0.57 | 0.66 | 0.64 |
EPS (Diluted) | - | 0.97 | 0.93 | 0.57 | 0.66 | 0.64 |
EPS Growth | - | 3.82% | 62.72% | -12.98% | 3.43% | 49.41% |
Free Cash Flow | 409.61 | 312.98 | 394.56 | 193.37 | 66.37 | 39.04 |
Free Cash Flow Per Share | - | 2.55 | 3.22 | 1.58 | 0.54 | 0.32 |
Dividend Per Share | - | - | 0.575 | 0.386 | 0.173 | 0.271 |
Dividend Growth | - | - | 49.05% | 122.58% | -35.94% | - |
Gross Margin | 15.14% | 15.29% | 15.00% | 14.92% | 14.66% | 14.15% |
Operating Margin | 2.94% | 3.06% | 2.95% | 3.02% | 3.11% | 2.13% |
Profit Margin | 1.24% | 1.04% | 1.13% | 0.81% | 1.03% | 1.22% |
Free Cash Flow Margin | 3.28% | 2.73% | 3.89% | 2.23% | 0.85% | 0.61% |
EBITDA | 431.46 | 404.46 | 342.15 | 295.65 | 273.34 | 162.72 |
EBITDA Margin | 3.45% | 3.53% | 3.37% | 3.41% | 3.50% | 2.54% |
D&A For EBITDA | 64.54 | 54.33 | 42.5 | 34.52 | 30.38 | 26.47 |
EBIT | 366.92 | 350.13 | 299.65 | 261.12 | 242.95 | 136.25 |
EBIT Margin | 2.94% | 3.06% | 2.95% | 3.02% | 3.11% | 2.13% |
Effective Tax Rate | 13.47% | - | 3.95% | 4.58% | - | - |